TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
IrenePharma Oy
Closing information (x1000 SEK)
Closing information | 2017/10 | 2016/10 | 2015/10 |
Turnover |
18,903
|
17,207
|
14,240 |
Financial expenses |
19
|
20
|
0 |
Earnings before taxes |
4,135
|
3,511
|
2,885 |
Total assets |
12,774
|
10,946
|
8,254 |
Current assets |
263
|
138
|
1,621 |
Current liabilities |
1,002
|
887
|
768 |
Equity capital |
11,781
|
10,058
|
7,485 |
- share capital |
29
|
30
|
28 |
Financial ratios
Fiscal year | 2017/10 | 2016/10 | 2015/10 |
Solvency |
92.2%
|
91.9%
|
90.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
21.9%
|
20.4%
|
20.3% |
Return on assets (ROA) |
32.5%
|
32.3%
|
35.0% |
Current ratio |
26.2%
|
15.6%
|
211.1% |
Return on equity (ROE) |
35.1%
|
34.9%
|
38.5% |
Change turnover |
1,926
|
2,219
|
347 |
Change turnover % |
11%
|
15%
|
2% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/10 | 2016/10 | 2015/10 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.